Literature DB >> 2057006

Gastrointestinal symptoms in Parkinson's disease.

L L Edwards1, R F Pfeiffer, E M Quigley, R Hofman, M Balluff.   

Abstract

We have investigated the prevalence of gastrointestinal (GI) symptoms in 98 individuals with Parkinson's disease (PD) and in a control group of 50. Seventy-nine of those with PD were being treated with dopaminergic medications and 19 were untreated. Those symptoms occurring more frequently in PD patients than in controls included abnormal salivation, dysphagia, nausea, constipation, and defecatory dysfunction. Except for defecatory dysfunction, symptoms did not correlate with treatment but instead correlated with disease severity. This suggests that the GI symptoms of PD reflect direct involvement in the GI tract by the primary disease process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2057006     DOI: 10.1002/mds.870060211

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  82 in total

Review 1.  Constipation in neurological diseases.

Authors:  K Winge; D Rasmussen; L M Werdelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease.

Authors:  Anne Damian; Charles H Adler; Joseph G Hentz; Holly A Shill; John N Caviness; Marwan N Sabbagh; Virgilio G H Evidente; Thomas G Beach; Erika Driver-Dunckley
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

3.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 4.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

5.  Determinants of autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Alexei Korchounov; Kirn R Kessler; Nikolay N Yakhno; Igor V Damulin; Hayo I Schipper
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 6.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

7.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

8.  Quantitative assessment of oral and pharyngeal function in Parkinson's disease.

Authors:  H Nilsson; O Ekberg; R Olsson; B Hindfelt
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

9.  Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy.

Authors:  Susan Toebosch; Vera Tudyka; Ad Masclee; Ger Koek
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 10.  Prevalence and definition of drooling in Parkinson's disease: a systematic review.

Authors:  J G Kalf; B J M de Swart; G F Borm; B R Bloem; M Munneke
Journal:  J Neurol       Date:  2009-03-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.